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Abstract
Background : One of the major cellular serine/threonine protein phosphatases is protein
phosphatase type 1 (PP1). Studies employing many eukaryotic systems all point to a crucial role for
PP1 activity in controlling cell cycle progression. One physiological substrate for PP1 appears to be
the product of the retinoblastoma susceptibility gene (pRB), a demonstrated tumor suppressor.
The growth suppressive activity of pRB is regulated by its phosphorylation state. Of critical
importance is the question of the in vivo effect of PP1 activity on pRB and growth regulation. As a
first step towards addressing this question, we developed an inducible PP1 expression system to
investigate the regulation of PP1 activity.
Results : We have established a cell line for inducing protein expression of the type 1, alpha-
isotype, serine/threonine protein phosphatase (PP1α). A plasmid encoding a fusion protein of the
catalytic subunit of PP1α with a 6-histidine peptide (6His) and a peptide from hemagluttinin (HA)
was transfected into the UMUC3 transitional cell carcinoma cell line, previously transfected with
the reverse tetracycline transactivator plasmid pUHD172-1neo. A stable cell line designated
LLWO2F was established by selection with hygromycin B. 6His-HA-PP1α protein appeared in cell
lysates within two hours following addition of doxycycline to the culture medium. This protein
localizes to the nucleus as does endogenous PP1α, and was shown to associate with PNUTS, a PP1-
nuclear targeting subunit. Like endogenous PP1α, immunocomplexed 6His-HA-PP1α is active
toward phosphorylase a and the product of the retinoblastoma susceptibility gene, pRB. When
forcibly overexpressing 6His-HA-PP1α, there is a concomitant decrease in endogenous PP1α
levels.
Conclusions : These data suggest the existence of an autoregulatory mechanism by which PP1α
protein levels and activity remain relatively constant. RT-PCR analyses of isolated polysome
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Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/12fractions support the notion that this putative autoregulatory mechanism is exerted, at least in part,
at the translational level. Implications of these findings for the study of PP1α function in vivo are
discussed.
Background
One of the major cellular serine/threonine protein phos-
phatases is protein phosphatase type 1 (PP1) [1]. An
abundant enzyme expressed in all cells, complex regula-
tion of PP1 is thought to be essential for proper temporal
and spatial regulation of PP1 catalytic activity towards
individual substrates [2]. Three different isotypes of the
catalytic subunit, designated PP1α, PP1δ, and PP1γ1, are
expressed in many different cell types [3]. Studies employ-
ing many eukaryotic systems all point to a crucial role for
PP1 activity in controlling cell cycle progression, and an
absolute requirement of this activity for mitotic exit [4–7].
There is also evidence to suggest that phosphorylation of
PP1 and its associated proteins by the cyclin-dependent
kinases may regulate PP1 activity in a cell cycle stage-
dependent manner [8–10]. Hence, current efforts are
directed towards identification of cell cycle-dependent
substrates for PP1, and how regulation of PP1 activity
towards these substrates controls the cell division cycle.
One physiological substrate for PP1 appears to be the
product of the retinoblastoma susceptibility gene, pRB
[11–13], a demonstrated tumor suppressor. The cell
growth and tumor suppressive activity of pRB is regulated
by its phosphorylation state. pRB phosphorylation varies
as a function of cell cycle phase; during G1 the hypophos-
phorylated form predominates, while the hyperphospho-
rylated form accumulates during S, G2 and M phase [14–
16]. It is this hypophosphorylated form of pRB present
during early and mid G1 which functions to modify gene
expression. This is achieved by complexing with transcrip-
tion factors resulting in repression [17] or stimulation
[18] of transcription. Under conditions favoring prolifer-
ation, the phosphorylation of pRB via cyclin-dependent
kinases (CDKs) in mid-to-late G1 phase results in libera-
tion of E2F and other pRB-bound transcription factors,
which then activate the transcription of S-phase genes
[19]. In late M phase, pRB returns to its growth suppres-
sive, hypophosphorylated form due to the action of a
pRB-directed protein phosphatase belonging to the type 1
class of serine/threonine protein phosphatases
[11,20,21].
Of critical importance is the question of the in vivo effect
of PP1 activity on pRB and growth regulation. To date,
several techniques have been employed in this regard to
demonstrate PP1 actions in intact cells. Berndt et. al. [22]
used electroporation to introduce PP1 protein into tissue
culture cells having noted that previous genetic attempts
to accomplish overexpression were not readily accom-
plished. Using this technique, they showed a G1 block by
PP1 that was dependent upon the presence of pRB. In
another report, micro-injection of PP1 decreased extracta-
bility of pRB from nuclei, presumably by increasing
dephosphorylation and increasing association with
nuclear proteins thereby playing a role in G1/S transition
inhibition [13]. Micro-injection of antibodies to the PP1
catalytic subunit has been shown to block cells in met-
aphase [23]. Since this is the time during mitosis when
pRB is normally dephosphorylated [11,24], it is tempting
to speculate that prevention of pRB dephosphorylation by
inhibiting PP1 activity impedes an orderly progression
through mitosis, perhaps contributing towards a trans-
formed phenotype.
Here, using the tetracycline induction system [25], we
developed an inducible PP1 expression system to investi-
gate the regulation of PP1 activity. We view this as a first
step towards addressing the question of the in vivo effect
of PP1 activity on pRB and growth regulation. Our results
support the notion that induced PP1α protein functions
identically to endogenous PP1α with respect to non-cata-
lytic subunit binding and activity towards phosphorylase
a and the tumor suppressor pRB. Localization of this pro-
tein to the nucleus also mirrors that of endogenous PP1α
in vivo. When using this system to forcibly overexpress
6His-HA-PP1α, there is a concomitant decrease in endog-
enous PP1α levels, suggesting the existence of an autoreg-
ulatory mechanism by which PP1α protein levels remain
constant. RT-PCR analyses of isolated polysome fractions
supports the notion that this putative autoregulatory
mechanism is exerted, at least in part, at the translational
level.
Results and Discussion
Induction of 6His-HA-PP1 in LLW02F cells
Figure 1 shows construct of the tetracycline-inducible
plasmid used to express 6His-HA-PP1α. As shown in Fig-
ure 2A, 24 hr incubation with doxycycline in the medium
has no appreciable effect on endogenous PP1α protein
expression in the untransfected parent cell line (UMUC3)
or a cell line transfected with the reverse tetracycline trans-
activator plasmid pUHD172-1neo only (LLWO1). A time
course of induction by doxycycline was then carried out in
stable clone LLWO2F. Harvested at various time intervals,
whole-cell lysates were prepared and the proteins were
separated by SDS-PAGE for western blotting using anti-
body to the hemagglutinin tag. As shown in Figure 2B, aPage 2 of 12
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was detected. A clear differential of expression of 6His-
HA-PP1α (indicated at the left of the panel) was observed
at 1.5 hours after addition of doxycycline, which became
more pronounced at later time points. The doxycycline-
independent increase in 6His-HA-PP1α is attributed to
background expression when using this system [25]. As
predicted for a protein under the control of the doxycy-
cline-inducible promoter, the abundance of 6His-HA-
PP1α decreases in the absence of the inducer over time
(Figure 2C). Subsequent time course experiments revealed
peak abundance occurring between 16 and 24 hr, and
remaining constant thereafter for at least 72 hr, at which
time the experiment was terminated. As such, we have
chosen the 24 hr induction time for all subsequent exper-
iments to ensure peak abundance of the induced 6His-
HA-PP1α.
As shown in Figure 2C, a significant reduction in 6His-
HA-PP1α abundance can be observed between 3 and 12
hrs following removal of doxycycline. This reduction con-
tinued through the 24 hr time point at which time the
experiment ended. Taken together, these data confirm the
dependence of 6His-HA-PP1α protein production on the
The 6His-HA-PP1α-pTEP4m plasmidFigure 1
The 6His-HA-PP1α-pTEP4m plasmid. The plasmid contains the 6His-HA-PP1α fusion gene under the control of the TetO/
CMV promoter. This promoter is active in the presence of the rtTA-nls protein and doxycycline. The plasmid contains an amp-
icillin resistance gene (Ampr) for selection in bacteria and the hygromycin resistance gene for selection in eukaryotic cells.Page 3 of 12
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expression of PP1α. As expected [25], some low-level
expression of 6His-HA-PP1α in the absence of the inducer
doxycycline can also be detected.
Biological and Biochemical Characterization of Inducible 
6His-HA-PP1α
To begin addressing the biological and biochemical char-
acterization of inducible PP1α, we next localized this pro-
tein in situ using immunohistochemistry. As shown in
Figure 3, there is a predominant nuclear localization of
the hemagglutinin epitope (panel A) compared to the
low-level cytoplasmic and nuclear background reactivity
seen in the uninduced LLWO2F control cells (panel B).
Thus, not only can doxycycline-induced expression of
PP1α be detected immunohistochemically, but localiza-
tion of this protein appears to be identical to that of
endogenous PP1 [26].
Targeting of PP1 to the nucleus is due in part to a PP1-
associated nuclear targeting subunit (PNUTS; [27]). To
further investigate the properties of inducible PP1α, we
performed coprecipitation studies to determine if PNUTS
can also be found associated with 6His-HA-PP1α.
Towards this goal, a fusion protein of GST and PNUTS was
tested for the ability to capture induced PP1α. Lysates
from induced LLWO2F cells were combined with GST-
alone- or GST-PNUTS-loaded glutathione Sepharose
beads. Following separation by SDS-PAGE and western
blotting, antibody to hemagglutinin was used to detect
any associated 6His-HA-PP1α. Antibody reactivity would
indicate a link from the GST epitope to the hemagglutinin
epitope via a PNUTS to PP1α interaction. As shown in Fig-
ure 4, the hemagglutinin epitope was captured by the
GST-PNUTS fusion protein, but not the GST-alone pro-
tein. These data support the idea that induced PP1α and
the nuclear targeting PP1-associated protein PNUTS can
form a complex. These results further support the view
that induced PP1α behaves similarly if not identically to
endogenous PP1α, and provides a possible mechanistic
explanation for 6His-HA-PP1α localization to the
nucleus.
Two different approaches were taken to address the bio-
chemical activity of inducible PP1α. First, immunocom-
plexed 6His-HA-PP1α was tested for its ability to
dephosphorylate phosphorylase a. Phosphorylated on a
single serine residue, this substrate is often used to moni-
tor the biochemical activity of PP1 in vitro [28]. As shown
in Figure 5, greater phosphatase activity is detected in
immunoprecipitates from induced LLWO2F cell lysates
compared to uninduced. This is consistent with the
notion that inducible PP1α is enzymatically active. Our
second approach involved testing immunopurified 6His-
HA-PP1α for its ability to dephosphorylate the growth
A. Doxycycline has no effect on PP1α protein expression in contr l cell sFigure 2
A. Doxycycline has no effect on PP1α protein expression in 
control cell lines. Equal quantities (50 ug) of whole-cell 
lysates harvested in the absence (indicated above the lanes 
with a (-) symbol), or presence (at 24 hr following addition, 
indicated above the lanes with a (+) symbol), of doxycycline 
were separated by SDS-PAGE and subjected to immunoblot-
ting using antibody specific for PP1α. UMUC3 – parent cell 
line from which stable expressor LLWO2F was selected; 
LLWO1 – cell line generated from UMUC3 which was stably 
transfected with the reverse tetracycline transactivator plas-
mid pUHD172-1neo only. B – Doxycycline induces a protein 
in LLW02F cells that is recognized by antibody to hemaggluti-
nin. Equal quantities (50 ug) of whole-cell lysates harvested at 
the various time points in hours after doxycycline addition 
(indicated above each lane) were separated by SDS-PAGE 
and subjected to immunoblotting as described in Materials 
and Methods. C – Time-course of recovery from doxycycline 
induction. LLWO2F cells were induced for 24 hr. At the end 
of this time, equal quantities (50 ug) of whole-cell lysates har-
vested at the various time points in hours following removal 
of doxycycline (indicated above each lane) were separated by 
SDS-PAGE and subjected to immunoblotting with antibody 
to hemagglutinin.
UMUC3           LLWO1
DOX -    +            -     + 
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the ability of immunocomplexed endogenous PP1 to
dephosphorylate pRB [20], we followed the same experi-
mental approach. Figure 6 shows a significant decrease in
the 32P radiolabel intensity for pRB following incubation
with the anti-hemagglutinin immunoprecipitate com-
pared to the normal mouse IgG control immunoprecipi-
tate. In addition, okadaic acid, a potent inhibitor of PP1
activity [29], significantly inhibits pRB dephosphoryla-
tion in this reaction. Taken together, these data indicate
that inducible PP1α is biochemically active.
Upregulation of inducible 6His-HA-PP1α coincides with 
downregulation of endogenous PP1α
One prediction would be that by increasing expression of
the catalytic subunit of PP1α, overall PP1-specific activity
within the cell would increase. To address this, we tested
the phosphatase activity of LLWO2F whole-cell lysate
using phosphorylase a as the substrate. To inhibit any
endogenous PP2A activity, which can also dephosphor-
ylate phosphorylase a and thus interfere with PP1 activity
measurements, these assays were carried out in the pres-
ence of 5 nM okadaic acid, which does not inhibit PP1
activity [30]. Although reproducible, we observed only
modest increases in PP1-specific activity found in lysates
from induced cells compared to the uninduced controls
(Figure 7). One possible explanation for this finding is
that the overall level of PP1α within the cell remains rela-
tively constant regardless of induction. Indeed, a time
Immunohistochemistry with the antibody to hemagglutinin shows doxycycline-dependent xpression of 6His-HA-PP1α in vivoFigure 3
Immunohistochemistry with the antibody to hemagglutinin 
shows doxycycline-dependent expression of 6His-HA-PP1α 
in vivo. LLWO2F cells were grown in 12 well tissue culture 
plates and induced for 24 hours prior to fixation and staining 
as described in Materials and Methods. Panel A – Induced; 
Panel B – Uninduced.
Coprecipitation of 6His-HA-PP1α with GST-PNUTSFigure 4
Coprecipitation of 6His-HA-PP1α with GST-PNUTS. Doxy-
cycline-induced LLWO2F cell lysates were mixed with either 
GST or GST-PNUTS bound to glutathione-Sepharose beads, 
washed, and the bound proteins separated by SDS-PAGE and 
then immunoblotted with antibody to hemagglutinin. Position 
of 6His-HA-PP1α is indicated to the left of the panel, and is 
present only in the GST-PNUTS lane. The band above 6His-
HA-PP1α, which is also present in the GST-alone lane, 
results from non-specific reactivity with the secondary anti-
body (horse-radish peroxidase-conjugated anti-IgG) used for 
chemiluminescent detectionPage 5 of 12
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cell lysates using antibody to PP1α revealed diminution
of the endogenous PP1α signal after 4 hr of induction,
while the 6His-HA-PP1α signal increased (Figure 8). To
further test this hypothesis, immunoprecipitation and
western blotting experiments were carried out using PP1
isoform-specific antibodies. As shown in Figure 9, top
panel, induced (approximate molecular weight of 40
kDa) and endogenous (approximate molecular weight of
37 kDa) PP1α are clearly resolved by SDS-PAGE. As pre-
dicted, both proteins are recognized by antibody specific
for PP1α when performing immunoprecipitation or west-
ern blotting. Immunoprecipitation using PP1α antibody
followed by western blotting using the same anti-PP1α
reveals a reciprocal relationship in PP1α abundance fol-
lowing doxycycline induction; endogenous PP1α levels
decrease in response to increasing levels of 6His-HA-PP1α
(top panel, compare left two lanes). This difference in
abundance is more striking in the whole-cell lysate lanes;
endogenous PP1α fails to be detected in lysates prepared
from induced cells (compare middle two lanes). Parallel
experiments performed using the same lysate and anti-
body to hemagglutinin for immunoprecipitation and
western blotting show the position of 6His-HA-PP1α and
the fact that endogenous PP1α is not recognized by this
antibody (bottom panel). Western blotting for additional
isoforms of PP1 reveals that this reduction in PP1α fol-
lowing induction is isotype-specific; when 6His-HA-PP1α
levels increase, concomitant with a decrease in PP1α lev-
els, PP1δ and PP1γ1 levels remain relatively unchanged
from those found in uninduced cell lysate (Figure 10).
Taken together, these data suggest that an as yet unde-
scribed negative-feedback or autoregulatory mechanism
exists for PP1α which contributes towards maintaining a
constant level of protein expression and enzyme activity.
RT-PCR of polysome and total RNA specific for 
endogenous PP1α and 6His-HA-PP1α
To address the possible autoregulatory mechanism(s) of
PP1α expression and activity, we analyzed the RNA levels
of both endogenous PP1α and induced 6His-HA-PP1α.
For uninduced cells, only endogenous PP1α RNA can be
found associated with polysomes (Figure 11, second
lane). While some 6His-HA-PP1α RNA can be detected in
the total RNA, the majority PP1α RNA detected in the
total preparation is endogenous (fourth lane). In contrast,
Dephosphorylation of phosphorylase a by anti-hemagglutinin immuno recipitates from uninduced (Control) and ind ced (Doxycycline) LLW02 cellFigure 5
Dephosphorylation of phosphorylase a by anti-hemagglutinin 
immunoprecipitates from uninduced (Control) and induced 
(Doxycycline) LLW02 cells. Activity was assayed by the 
release of [32P] H3PO4 from radiolabeled phosphorylase a 
(1–2 × 105 cpm/nmol). 1 unit of activity releases 1 nmol of 
phosphate/min at 30°C.
Dephosphorylation of pRB by anti-hemagglutinin immuno-pr cipitates from i duced LLW02 cellsFigure 6
Dephosphorylation of pRB by anti-hemagglutinin immuno-
precipitates from induced LLW02 cells. Samples were run in 
duplicate. Normal mouse IgG immunoprecipitate was used as 
a negative control. Anti-hemagglutinin immunoprecipitate, 
reaction run in the presence of okadaic acid (100 nM), a 
demonstrated PP1 inhibitor, was an additional negative con-
trol. Anti-hemagglutinin immunoprecipitate, revealing a 
decrease in 32P-labeled pRB band intensity, indicating removal 
of phosphate groups by 6His-HA-PP1α.Page 6 of 12
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PP1 activity in lysates of cells expressing 6His-HA-PP1α. Cells were cultured for 24 hr either in the absence (closed diamonds) 
or presence (closed squares) of doxycycline. PP1 was assayed using the indicated amounts of lysate/assay. 5 nM okadaic acid 
was used to inhibit PP2A during the assay. 1 unit of PP1 activity releases 1 nmol of Pi/min at 30°C.
Time course of induction followed by western blotting of whole cell lysates using antibody to PP1αF gure 8
Time course of induction followed by western blotting of whole cell lysates using antibody to PP1α. Equal quantities (50 ug) of 
whole-cell lysates harvested at the various time points in hours after doxycycline addition (indicated above each lane) were 
separated by SDS-PAGE and subjected to immunoblotting using antibody specific for PP1α. Positions of endogenous PP1α and 
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lane), there is more 6His-HA-PP1α RNA associated with
polysomes than endogenous PP1α. However, both mes-
sages appear to be present at the same level in the total
RNA preparation (fifth lane). This apparent preference for
6His-HA-PP1α RNA association with polysomes suggest
that autoregulation takes place, at least in part, at the
translational level.
Conclusions
We observed that endogenous PP1α protein levels
decrease in response to increasing levels of induced 6His-
HA-PP1α protein. This observation suggests that an as yet
undescribed negative-feedback or autoregulatory mecha-
nism exists for PP1α which contributes towards
maintaining a constant level of this enzyme. Given the
difficulty in achieving overexpression of PP1 protein and
activity in mammalian cells, this suggestion provides an
attractive explanation. This putative mechanism appears
to be isotype-specific, since the protein levels of PP1δ and
PP1γ1 remained relatively unchanged in response to
induced expression of PP1α. Precedent for an autoregula-
tory mechanism comes from a report by Baharians and
Schonthal [31], in which they demonstrate endogenous
PP2A protein levels decrease in the presence of increasing
amounts of forcibly-expressed exogenous PP2A. Their
report also provides evidence that this control is exerted at
the translational level and does not involve regulation of
transcription or RNA processing. Using a similar approach
of analyzing mRNA association with ribosomes as a meas-
ure of translation efficiency, a similar level of translational
control also appears to exist for PP1α. If mRNA associa-
tion with ribosomes is truly a measure of translation effi-
ciency, one conclusion from these data is that in
doxycycline-induced cells, 6His-HA-PP1α RNA is more
efficiently translated than endogenous PP1α. This would
help to explain why we observed a decrease in
PP1α isoform-specific antibody immunoprecipitation and detection of endogenous and induced PP1α by wester  blottingFigure 9
PP1α isoform-specific antibody immunoprecipitation and 
detection of endogenous and induced PP1α by western blot-
ting. PP1α isoform-specific antibody was used to immuno-
precipitate proteins from equal quantities (50 ug) of 
uninduced (first lane from the left, top panel) and induced 
LLWO2F cell lysate (second lane from the left, top panel). 
The precipitated proteins were then separated by SDS-PAGE 
and immunoblotted with the same isoform-specific antibody. 
The positions of 6His-HA-PP1α and PP1α are indicated to 
the left of the top panel. Whole-cell lysates (10 ug) were sep-
arated in the next two lanes. Last lane contains 1 ug of puri-
fied recombinant PP1α as a control for endogenous PP1α 
(37 kDa). Bottom panel shows identical experiment using 
antibody to hemagglutinin for immunoprecipitation and 
immunodetection. Although low levels of 6His-HA-PP1α can 
be detected in cell lysate from uninduced cells following 
western blotting, this protein is almost undetectable in the 
same lysate following immunoprecipitation and western blot-
ting. This observation is most likely due to low efficiency of 
immunoprecipitation.
Isoform-specific antibody detection of PP1 by western blot-ting induced and un nduce  LLWO2F whole-cell lysatesFi u e 10
Isoform-specific antibody detection of PP1 by western blot-
ting induced and uninduced LLWO2F whole-cell lysates. Dif-
ferent amounts (5 ug for the first and third lanes, 10 ug for 
the second and fourth lanes) of lysate from induced and unin-
duced cells were separated by SDS-PAGE in parallel and then 
immunoblotted using PP1α-, PP1δ-, and PP1γ1-specific anti-
body. Results illustrate downregulation of endogenous PP1α 
in response to increasing amounts of induced 6His-HA-PP1α, 
while the levels of PP1δ and PP1γ1 remain relatively constant. 
Lane C – control lane of isoform-specific antibody immuno-
precipitation of respective isoforms from 50 ug of uninduced 
cell lysate.Page 8 of 12
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induced cells. Since we did not perform rigorous analyses
on PP1α regulation of transcription or RNA processing,
we cannot rule out the possibility that some level of tran-
scriptional control also exists. Indeed, the abundance of
endogenous PP1α RNA found in uninduced cells appears
equal to or greater than the combined abundance of
endogenous and 6His-HA-PP1α RNA (Figure 9), support-
ing the notion that some level of translational control
may also exist.
These findings, provided by the development of this
inducible PP1 expression system, will afford new research
opportunities aimed towards addressing the question of
how PP1 activity is regulated. This putative autoregulatory
mechanism for the catalytic subunit may help to explain
why the overall abundance of PP1 during the various
phases of the cell cycle remains relatively constant [32].
Historically, regulation of PP1 catalytic activity has
resulted from associated subunits inhibiting or targeting
the catalytic subunit towards substrates [33]. While the
PP1 catalytic subunit is not found alone in the cell, such
unassociated catalytic subunits have been shown to be
active, at least in vitro. Although speculative, there may be
a threshold amount of catalytic subunit in vivo above
which associated proteins are limiting. Such a situation
may compromise the ability of associated proteins to
effectively regulate PP1 catalytic activity. To guard against
this scenario, control over the amount of PP1 catalytic
subunit present via an autoregulatory mechanism would
be beneficial.
In summary, we report on the development of an induci-
ble mammalian cell expression system for the catalytic
subunit of the α-isotype for PP1. This protein behaves
similarly if not identically to endogenous PP1α with
respect to nuclear localization, complex formation to a
recently described PP1-associated nuclear targeting pro-
tein, and in vitro enzymatic activity towards phosphory-
lase a and the cell growth and tumor suppressor protein
pRB.
The data presented here validate a useful system with
which to manipulate PP1 activity in vivo for the purpose of
functional studies. Just as is the case for PP2A [31], it
seems clear that efficient overall increases in PP1 protein
abundance may not be achieved due to a putative negative
feed-back or autoregulatory mechanism. However,
induced expression of exogenous PP1 which behaves
identically to endogenous PP1 while remaining physically
distinguishable can facilitate the use of mutants to address
functional questions, particularly in the area of cell cycle
regulation and tumor cell growth suppression. Indeed, the
use of a constitutively active mutant of PP1 has already
been shown to result in pRB-dependent G1 arrest in
human cancer cells [22]. Placing this mutant into the
inducible expression system described here has the poten-
tial to down-regulate expression of wild-type endogenous
PP1. Doing so in a timed, controlled manner will permit
in vivo studies addressing PP1 function during discrete




The rabbit PP1α cDNA in pDR540 [34] was ligated into
pcDNA3 (Invitrogen) to create a fusion encoding 6 histi-
dines (6-His) followed by an epitope (YPYDVPDYA) from
the Hemophilus influenza hemagglutinin protein (HA).
The sequence and reading frame was validated by BigDye
DNA sequencing (PE Applied Biosystems). The fusion
gene was then cut from the 6His-HA-PP1α-pcDNA3 plas-
mid and ligated into pTEP4m, which contains a
tetracycline response element for inducible expression
[25], and a hygromycin resistance gene for selection in
eukaryotic cells (see Figure 1). pUHD172-1neo [25]
encodes the reverse tetracycline transactivator protein
fused with a nuclear localization signal (rtTA-nls). In
addition to the rtTA-nls gene under control of the CMV
promoter, the plasmid contains neomycin and ampicillin
antibiotic resistance genes.
Cell Culture, Transfection, and Selection
The UMUC3 cell line was obtained from the American
Type Culture Collection. The cells were maintained in
Dulbecco's minimal essential medium(Life Technologies)
RT-PCR of polysome and total RNA specific for endogenous PP1α and 6His-HA-PP1αFigure 11
RT-PCR of polysome and total RNA specific for endogenous 
PP1α and 6His-HA-PP1α. PCR products from polysome and 
total RNA from induced and uninduced cell lysates were pre-
pared and analyzed as described in Materials and Methods. 
MW – molecular mass standard ladder.
-       +      -      +
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penicillin and 20 ug/ml streptomycin. Cells were incu-
bated at 37C, in a 5% carbon dioxide containing
atmosphere.
Plasmid DNA was introduced into cultured cells using
Lipofectamine (Life Technologies). 2 ug of plasmid DNA
and 25 ul of Lipofectamine were combined in 200 ul of
Opti-mem media (Life Technologies) and allowed to
stand at room temperature for 30 minutes. This mixture
was diluted to 1 ml with Opti-mem and applied to cells in
one well of 6-well tissue culture plates. After two hours, 1
ml of complete medium was added to each well. After
twenty-four hours the medium was replaced with com-
plete medium.
Transfection of UMUC3 cells with pUHD172-1neo was
followed 48 hr later by selection using geneticin. Isolated
colonies were obtained at 800 µg/ml. These cells were pas-
saged and expanded before transfection with pBI-EGFP
(Clontech), which contains the enhanced green fluores-
cent protein coding sequence under control of a bi-direc-
tional tetracycline response element. At the end of the 2 hr
transfection (as described above) the medium was
replaced with complete medium with and without doxy-
cycline at 1 ug/ml final concentration. 24 hr later the cells
were examined by fluorescence microscopy. The presence
of doxycycline dependent green fluorescence was
indicative of stable transfection with pUHD172-1neo
encoding the rtTA-nls protein and transient transfection
with pBi-EGFP. Parallel cultures were then passaged and
transfected with 6His-HA-PP1α-pTEP4m. Selection with
hygromycin was begun 48 hr later. Isolated colonies were
obtained at 100 ug/ml hygromycin and were passaged
and diluted to extinction. Six cell lines, designated
LLW02A through LLW02F, were established. The LLW02F
cell line was used for all subsequent experiments. This
choice was based on high levels of induced PP1α expres-
sion as assayed by immunoblotting. Doxycycline was
used at 1 ug/ml for induction.
SDS-PAGE and Immunoblotting
Cells were lysed for 15 min at 4°C in EBC buffer (50 mM
Tris-HCl, pH 8.0, 120 mM NaCl, 0.5% Nonidet P-40)
containing 10 ug/ml of the protease inhibitors aprotinin,
leupeptin, and phenylmethylsulfonylfluoride (PMSF).
The lysates were cleared by centrifugation at 14,000 × g for
10 minutes. Electrophoresis was performed in SDS-poly-
acrylamide gels [35] using the indicated amount of total
cell protein [36]. After electrophoresis, the proteins were
transferred to nitrocellulose paper in buffer containing 25
mM Tris-HCl, 192 mM glycine, 20% v/v methanol, and
0.01% SDS, pH 8.5 [37]. Residual protein binding sites on
the nitrocellulose were blocked by incubation for 30 min-
utes in TBST (25 mM Tris-HCl, pH 8.0, 150 mM NaCl,
0.5% Tween-20) containing 4% non-fat dry milk. Next,
the nitrocellulose was incubated in TBST containing 2%
non-fat dry milk containing primary antibody directed
towards the indicated protein. Following three washes of
10 min each with TBST, the nitrocellulose was probed
with horse-radish peroxidase-conjugated anti-IgG
(Promega, Madison, WI) and developed using chemilu-
minescence detection (Pierce, Rockford, IL) according to
the manufacturer's instructions.
Immunohistochemistry
Cell monolayers were rinsed 3 times with PBS, fixed for 10
minutes in -20oC methanol, and then air dried for 1 hr.
The cells were rehydrated for 20 min in PBS before block-
ing for 20 min with diluted normal horse serum. The cells
were then incubated for 30 min with a 1:200 dilution of
monoclonal antibody HA.11 (BAbCO, Richmond, Cali-
fornia) which recognizes the influenza hemagglutinin
epitope YPYDVPDYA. The cells were then washed 4 times
PBS and incubated with biotinylated secondary antibody
for 30 min at room temperature. Following 4 rinses with
PBS, the cells were then incubated for 30 min at room
temperature with avidin-biotin-peroxidase complexes.
The cells were rinsed again in PBS 4 times. Diaminoben-
zidine (DAB substrate kit for peroxidase, Vector Laborato-
ries, Burlingame, CA) was used as the final chromogen.
The cells were incubated with this compound for 8 min.
Hematoxylin was used as the nuclear counterstain. Fol-
lowing dehydration in ethanol and air drying, the cell
monolayers were flooded with glycerol for subsequent
observation, photography, and storage.
Phosphorylase Phosphatase Activity of Immunocomplexed 
6His-HA-PP1α
Phosphorylase phosphatase activity was measured as the
release of trichloroacetic acid (TCA) soluble counts from
32P-phosphorylase a according to Cohen et. al. [38]
Briefly, radiolabeled phosphorylase a was synthesized by
taking phosphorylase b (Sigma), at a concentration of 10
mg/ml, and incubating with 0.2 mg/ml phosphorylase
kinase (Sigma) for 1.5 hours at 30°C in kinase reaction
buffer (100 mM Tris-HCl; 100 mM sodium glycerol-1-
phosphate, pH 8.2; 0.1 mM CaCl2, 10 mM magnesium
acetate, and 0.2 mM [g-32P]ATP {106 cpm/nmol}).
Enzyme samples were immunocomplexed 6His-HA-
PP1α.
Preparation of [32P]pRB substrate and pRB-directed 
phosphatase activity assays
To assay pRB-directed phosphatase activity, [32P]-labeled
pRB substrate was prepared by immunoprecipitation with
monoclonal antibody to pRB, PMG3-245 (PharMingen),
from [32P]-labeled CV-1P cells as described previously
[20]. For the source of enzyme, immunocomplexed 6His-
HA-PP1α from induced LLWO2F cells were mixed andPage 10 of 12
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30 minutes at 30°C as previously described [20].
Phosphatase reactions were terminated by the addition of
SDS-PAGE sample buffer and boiling. Proteins were sepa-
rated on SDS-polyacrylamide gels. Gels were fixed, dried
subjected to autoradiography.
Type 1 Phosphatase Activity of Whole-Cell Lysates
PP1 was assayed by the release of [32P] H3PO4 from [32P]-
rabbit muscle phosphorylase a (1–2 × 105 cpm/nmol). 5
nM okadaic acid was used to inhibit PP2A during the
assay. 1 unit of PP1 activity releases 1 nmol of Pi/min at
30°C.
Immunoprecipitation using PP1 Isoform-specific antibody
LLWO2F cell extracts (50 ug) were immunoprecipitated
with approximately 1 ug of isoform-specific rabbit antise-
rum to PP1α as previously described [38]. Immunopre-
cipitation with 1 ug of normal rabbit serum served as a
negative control.
GST-PNUTS Affinity Chromatography
Induction of GST-PNUTS fusion protein synthesis and
isolation by affinity chromatography using glutathione-
Sepharose beads (Pharmacia) was performed as described
previously [32]. Induced LLWO2F cell extracts were then
incubated for 1 hour at 4°C with recombinant GST or
GST-PNUTS fusion protein bound to glutathione-Sepha-
rose. Bound proteins were washed with PBS, separated on
10 % SDS-polyacrylamide gels, and transferred to nitro-
cellulose. Protein blots were then developed using anti-
body to hemagglutinin for 6His-HA-PP1α detection.
Polysome isolation
Uninduced and induced LLWO2F cells (10 × 100 mm
dishes) were washed 3-times with ice-cold serum-free
DMEM containing 10 ug/ml cycloheximide. After the last
wash, cells were scraped into a final volume of 5 ml of this
same medium for each 10-dish treatment. The cells were
harvested with a brief centrifugation. The cell pellet was
resuspended in 0.5 ml lysis buffer (125 mM KCl, 12.5 mM
mgCl2, 10 mM Hepes, pH 6.8, 0.1 mM dithiothreitol, 10
ug/ml cycloheximide, 0.5% Triton X-100, 0.5% deoxy-
cholate) followed by 10 passages through a 22 gauge nee-
dle to lyse the cells. The resulting extracts were then
layered on the top of a 10–40% sucrose gradient (125 mM
KCl, 12.5 mM mgCl2, 10 mM Hepes, pH 6.8, 0.1 mM
dithiothreitol, 10 ug/ml cycloheximide) and centrifuged
at 4°C in a SW50.1 rotor at 48,000 rpm for 60 min. After
centrifugation, the gradient was fractionated in 200 ul
aliquots and analyzed at A260 using a Bio-Rad SmartSpec
3000. A single peak of A260 absorbance in the bottom por-
tion of the gradient was analyzed as polysome fraction.
RT-PCR analyses of PP1α mRNA
LLWO2F cells were induced with doxycycline (2 ug/ml)
for 24 hr. Negative control LLWO2F cells were not
induced with doxycycline. For total RNA experiments,
RNA was harvested from monolayered cells using
QIAshredder and Qiagen RNeasy mini-kit. Polysome RNA
was recovered from polysome fractions by first diluting
fractions in 3.5 volumes of lysis buffer from the Qiagen
RNeasy mini-kit and then continuing with the manufac-
turer's instructions. RNA was quantitated by UV spectrom-
etry. 1 ug total RNA (or 200 ng polysome RNA) was used
in first strand cDNA synthesis using SUPERSCRIPT II
reverse transcriptase (Life Technologies) following manu-
facturer's instructions. cDNA was extracted by one phenol
chloroform:isoamyl alcohol extraction followed by one
chloroform isoamyl alcohol extraction and then ethanol
precipitated. cDNA was resuspended in 20 ul water and
used in a 30-cycle PCR reaction with 1 uM of each of the
following four primers: {CCACGCTGTTTTGACCTCCAT-
AGAAGACAC, CACATAGTCCCCCAGAAAGAGGTAGTT-
GCT}, in which product only forms from 6His-HA-PP1α
cDNA, and {GACGCGGGCAAGCAGTCCCTCGAGAC-
CATTGCCTGCTG, CTGGAGACCCACGACCTGGCCT-
GCCGTTG}, in which product only forms from
endogenous PP1α cDNA. Reaction also contained 200
uM dNTPs, 1 mM Mg++, and 5 units Taq DNA polymerase
(Life Technologies) with supplied reaction buffer. 2 ul of
the PCR product was loaded onto a 1% agarose gel con-
taining ethidium bromide for UV visualization.
Authors' Contributions
JER, JWL, and EMM conceived the study and participated
in its design and execution. MPS participated in plasmid
constructions. PK performed RT-PCR and polysome
analysis. EV-M provided PP1-isoform specific antibodies
and participated in PP1 immunoprecipitations and west-
ern blots. Authors read and approved the final
manuscript.
Acknowledgements
We wish to thank Richard Furlanetto at the University of Rochester for the 
pTEP4 plasmid and Walter Stadler of the University of Chicago for the 
pTEP4m plasmid. The technical support of Josephine Morreale, Victoria 
Meyers, Mary O'Connell and Elaine Delvaux is gratefully acknowledged. 
This work was supported by NCI grant CA33148-14 (Leon L. Wheeless), 
The American Cancer Society Research Project Grant 98-108-01-TBE 
(J.W.L.) and the Sally Edelman and Harry Gardner Cancer Research Foun-
dation (J.W.L.).
References
1. Cohen P: The structure and regulation of protein
phosphatases Ann Rev Biochem 1989, 58:453-508.
2. Ingebritsen TS and Cohen P: Protein phosphatases: properties
and role in cellular regulation Science 1983, 221:331-338.
3. Shima H, Hatano Y, Chun YS, Sugimura T, Zhang Z, Lee EY and Nagao
M: Identification of PP1 catalytic subunit isotypes PP1
gamma 1, PP1 delta and PP1 alpha in various rat tissues Bio-
chem Biophys Res Commun 1993, 192:1289-1296.Page 11 of 12
(page number not for citation purposes)
Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/12Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
4. Cyert MS and Thorner J: Putting it on and taking it off: phospho-
protein phosphatase involvement in cell cycle regulation Cell
1989, 57:891-893.
5. Mumby MC and Walter G: Protein serine/threonine phos-
phatases: structure regulation, and functions in cell growth
Physiol Rev 1993, 73:673-699.
6. Kinoshita N, Ohkura H, Miyatani S and Yanagida M: Distinct, essen-
tial roles of type 1 and 2A protein phosphatases in the con-
trol of the fission yeast cell division cycle Cell 1990, 63:405-415.
7. Wera S and Hemmings BA: Serine/threonine protein
phosphatases Biochem J 1995, 311:17-19.
8. Villa-Moruzzi E: Activation of type-1 protein phosphatase by
cdc2 kinase FEBS Lett 1992, 304:211-5.
9. Yamano H, Ishi K and Yanagida M: Phosphorylation of dis2 pro-
tein phosphatase at the c-terminal cdc2 consensus and its
potential role in cell cycle regulation EMBO J 1994,
13:5310-5318.
10. Dohadwala M, da Cruz e Silva EF, Hall FL, Williams RT, Carbonara-
Hall DA, Nairn AC, Greengard P and Berndt N: Phosphorylation
and inactivation of protein phosphatase 1 by cyclin-depend-
ent kinases Proc Natl Acad Sci USA 1994, 91:6408-6412.
11. Ludlow JW, Glendening CL, Livingston DM and DeCaprio JA: Spe-
cific enzymatic dephosphorylation of the retinoblastoma
protein Mol Cell Biol 1993, 13:367-72.
12. Durfee T, Becherer K, Chen P-L, Yeh S-H, Yang Y, Kilburn AE, Lee
W-H and Elledge SJ: The retinoblastoma protein associates
with the protein phosphatase type 1 catalytic subunit Genes &
Develop 1993, 7:555-569.
13. Alberts AS, Thurburn AM, Shenolikar S, Mumby MC and Feramisco
JR: Regulation of cell cycle progression and nuclear affinity of
the retinoblastoma protein by protein phosphatases Proc Natl
Acad Sci USA 1993, 90:388-392.
14. Buchkovich K, Duffy LA and Harlow E: The retinoblastoma pro-
tein is phosphorylated during specific phases of the cell cycle
Cell 1989, 58:1097-1105.
15. Chen PL, Scully P, Shew JY, Wang JY and Lee WH: Phosphorylation
of the retinoblastoma gene product is modulated during the
cell cycle and cellular differentiation Cell 1989, 58:1193-1198.
16. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-
Worms H, Huang CM and Livingston DM: The product of the
retinoblastoma susceptibility gene has properties of a cell
cycle regulatory element Cell 1989, 58:1085-1095.
17. Nevins JR: E2F: a link between the Rb tumor suppressor pro-
tein and viral oncoproteins Science 1992, 258:424-429.
18. Udvadia AJ, Templeton DJ and Horowitz JM: Functional interac-
tions between the retinoblastoma (Rb) protein and Sp-fam-
ily members: superactivation by Rb requires amino acids
necessary for growth suppression Proc Natl Acad Sci USA 1995,
92:3953-3957.
19. Bartek J, Bartkova J and Lukas J: The retinoblastoma protein
pathway and the restriction point Curr Opin Cell Biol 1996,
8:805-814.
20. Nelson DA, Krucher NA and Ludlow JW: High molecular weight
protein phosphatase type 1 dephosphorylates the retinoblas-
toma protein J Biol Chem 1997, 272:4528-4535.
21. Nelson DA and Ludlow JW: Characterization of the mitotic
phase pRb-directed protein phosphatase activity Oncogene
1997, 14:2407-2415.
22. Berndt N, Dohadwala M and Liu CW: Constitutively active pro-
tein phophatase 1 causes Rb-dependent G1 arrest in human
cancer cells. Curr Biol 1997, 7:375-386.
23. Fernandez A, Brautigan DL and Lamb NJC: Protein phosphatase
type 1 in mammalian cell mitosis: chromosomal localization
and involvement in mitotic exit J Cell Biol 1992, 116:1421-1430.
24. Ludlow JW, Shon J, Pipas JM, Livingston DM and DeCaprio JA: The
retinoblastoma susceptibility gene product undergoes cell
cycle-dependent dephosphorylation and binding to and
release from SV40 large T Cell 1990, 60:387-396.
25. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W and Bujard H:
Transcriptional activation by tetracyclines in mammalian
cells Science 1995, 268:1766-1769.
26. Andreassen PR, Lacroix FB, Villa-Moruzzi E and Margolis RL: Differ-
ential subcellular localization of protein phosphatase-1
alpha, gamma1, and delta isoforms during both interphase
and mitosis in mammalian cells J Cell Biol 1998, 141:1207-1215.
27. Allen PB, Kwon Y-G, Nairn AC and Greengard P: Isolation and
characterization of PNUTS, a putative protein phosphatase
1 nuclear targeting subunit J Biol Chem 1998, 273:4089-4095.
28. Cohen P, Alemany S, Hemmings BA, Resink TJ, Stralfors P and Tung
HYL: Protein phosphatase-1 and protein phosphatase-2A
from rabbit skeletal muscle Meth Enzymol 1988, 159:390-408.
29. Bialojan C and Takai A: Inhibitory effect of a marine-sponge
toxin, okadaic acid, on protein phosphatases Biochem J 1998,
256:283-290.
30. Schonthal AH: Analyzing gene expressionwith the use of ser-
ine/threonine phosphatase inhibitors In Methods in Molecular
Biology, Protein Phosphatase Protocols Volume 93. Edited by: Ludlow JW.
Humana Press, Totowa, NJ; 1998:35-40. 
31. Baharians Z and Schonthal AH: Autoregulation of protein phos-
phatase type 2A expression J Biol Chem 1998, 273:19019-19024.
32. Ludlow JW and Nelson DA: Control and activity of type-1 ser-
ine/threonine protein phosphatase during the cell cycle Sem
Cancer Biol 1995, 6:195-202.
33. Zhang Z, Bai G, Deans-Zirattu S, Browner MF and Lee EYC: Expres-
sion of the catalytic subunit of phosphoryase phosphatase
(protein phosphatase-1) in Eschericia coli J Biol Chem 1992,
267:1484-1490.
34. Berndt N and Cohen PWT: Renaturation of protein phos-
phatase 1 expressed at high levels in insect cells using a bac-
ulovirus vector Eur J Biochem 1990, 190:291-297.
35. Laemmli UK: Cleavage of structural proteins during the
assembly of the head of bacteriophage T4 Nature 1970,
227:680-685.
36. Bradford MM: A rapid and sensitive method for the quantita-
tion of microgram quantities of protein utilizing the princi-
ple of protein-dye binding Anal Biochem 1976, 72:248-254.
37. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of
proteins from polyacrylamide gels to nitrocellulose sheets:
procedure and some applications Proc Natl Acad Sci USA 1979,
76:4350-4354.
38. Tognarini M and Villa-Moruzzi E: Analysis of the isoforms of pro-
tein phosphatase 1 (PP1) with polyclonal peptide antibodies
In Methods in Molecular Biology, Protein Phosphatase Protocols Volume 93.
Edited by: Humana Press, Totowa, NJ. Ludlow JW; 1998:169-183. Page 12 of 12
(page number not for citation purposes)
